If you have had Covid-19, you may be familiar with the feeling of exhaustion and weakness that can linger for weeks or months after the infection. This is not just a normal recovery process, but a sign of a serious condition called ME/CFS, or myalgic encephalomyelitis/chronic fatigue syndrome.
ME/CFS is a complex and poorly understood disorder that affects multiple systems in the body, especially the cardiovascular and mitochondrial systems. The cardiovascular system is responsible for delivering oxygen and nutrients to the tissues, while the mitochondrial system is responsible for producing energy from those resources. When these systems are disrupted, the tissues suffer from low perfusion and low energy, leading to symptoms such as fatigue, pain, cognitive impairment, and intolerance to physical or mental exertion.
In this study, Wirth et al. investigated how Covid-19 can cause damage to the cardiovascular and mitochondrial systems, and how this damage can contribute to ME/CFS. They used advanced imaging techniques to measure the blood flow and oxygen levels in the capillaries, the smallest blood vessels in the body, and the mitochondria, the powerhouses of the cells, in patients with ME/CFS and healthy controls.
They found that patients with ME/CFS had significantly lower capillary blood flow and oxygen levels than healthy controls, indicating a severe impairment of tissue perfusion. In addition, they found that patients with ME/CFS had lower mitochondrial function than healthy controls, indicating a reduced ability to produce energy. Moreover, they found that these two disturbances were strongly correlated, meaning that the worse the perfusion was, the worse the mitochondrial function was.
These findings suggest that Covid-19 can trigger a vicious cycle of tissue hypoxia and energy depletion that can persist long after the infection and cause chronic symptoms of ME/CFS. This cycle can be aggravated by physical or mental stress, which can further compromise the cardiovascular and mitochondrial systems.
The good news is that there are ways to break this cycle and improve the quality of life of patients with ME/CFS. One of them is to avoid overexertion and follow a pacing strategy that respects the individual limits of each patient. Another one is to use pharmacological or non-pharmacological interventions that can enhance tissue perfusion and mitochondrial function, such as vasodilators, antioxidants, or exercise training. These interventions should be tailored to each patient's needs and monitored by a specialist.
If you have had Covid-19 and are experiencing persistent fatigue or other symptoms of ME/CFS, do not ignore them or push yourself beyond your capacity. Seek medical help and get tested for ME/CFS. There is hope for recovery and you are not alone.

Comments
Post a Comment